Precision BioSciences (STU:PBS0) Short Percentage of Float


STU:PBS0 Precision BioSciences Inc STU:PBS0
46 GF Score
Price €7.10
GF Value €1.61
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Precision BioSciences Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

STU:PBS0 vs NBP, HUMA, ORMP: Short Percentage of Float Comparison

For the Biotechnology subindustry, Precision BioSciences's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Precision BioSciences Short Percentage of Float vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Precision BioSciences's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Precision BioSciences's Short Percentage of Float falls into.


STU:PBS0
46GF Score
Precision BioSciences Inc STU:PBS0
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Precision BioSciences (STU:PBS0) Overvalued in 2026?

Based on GuruFocus' analysis, Precision BioSciences stock appears to be overvalued. The current stock price of €7.10 is trading 341% above its estimated GF Value™ of €1.61. GuruFocus considers Precision BioSciences to be Significantly Overvalued.

Key valuation signals for STU:PBS0:

  • Short Percentage of Float:
  • GF Value™: €1.61 vs. price of €7.10 (341% above fair value)
  • GF Score™: 46/100 with 5 warning signs

No single metric tells the full story. See the STU:PBS0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Precision BioSciences Business Description

Other Exchanges DTIL:USA
Address 302 East Pettigrew Street, Dibrell Building, Suite A-100, Durham, NC, USA, 27701
Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).
46GF Score

Get the complete analysis for STU:PBS0

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.10
Price
€1.61
GF Value